RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly exceeding the previous year's EUR 833.5 million. EBITDA improved to EUR 57.0 million from EUR 46.7 million, and consolidated profit rose to EUR 22.5 million from EUR 14.7 million. The results were significantly impacted by immediate transformation costs established until November 2026 to offset higher personnel and material costs from prior years.
The Group treated 513,700 patients on an outpatient and inpatient basis from January to June, a 9% increase compared to 471,295 in the same period last year. This growth reflects the continuous expansion and improvement of regional healthcare provision. Investments in state-of-the-art medical technology are planned for 2026 at all sites, alongside further expansion of medical and therapeutic care offerings and the establishment of regional cooperation networks.
Notable developments include a strategic partnership in Hesse between Universitatsklinikum Marburg and Lungenfachklinik Immenhausen to enhance lung patient care. In Brandenburg, the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site has created a strong regional network, with cooperation agreements among the hospital, the City of Frankfurt (Oder), and the District of Oder-Spree ensuring coordinated assistance for affected children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: "Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently. In the face of mounting pressures, such collaboration across providers is the only way to ensure comprehensive and high-quality care to patients, especially in rural areas."
Dr. Stefan Stranz, also a Board member, criticized recent legislative changes: "The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks."
For the full year 2026, RHON-KLINIKUM AG expects revenues of EUR 1.7 billion within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates moderate improvements in non-financial indicators such as number of cases and cost weights. However, the forecast is subject to considerable uncertainties due to ongoing legislative processes, including the Hospital Reform Adjustment Act (KHAG) effective from 15 April 2026 and the SHI Contribution Rate Stabilisation Act (GKV-BStabG) adopted on 10 July 2026. These reforms aim to enhance quality and efficiency but will increase financial pressure on hospitals in the short term.
The company notes that it is not yet possible to reliably forecast the overall impact of regulatory interference, hospital reform implementation, and further legislative adjustments. Additionally, global crises and negative economic impacts are causing higher prices, supply bottlenecks, and market volatility. The Interim Report for the first half of 2026 is published on the company's website.
